Submit ICO / Airdrop ★ Get Promotion
ProjectsDeFiAirdropsSTOsPromotionMarks newsWatchlist ()
0
Stem Cell

Stem Cell

ICO Ended
13,291 Views
Visit Website
Last screenshot taken on
21 Mar 2020 .
Add to Watchlist
At SCI, we are devoted to the international research, development, and implementation of stem cell therapy. We are also expanding our network with professionals, labs, clinics, hospitals, and nonprofit organizations. Our ultimate goal at SCI is to connect people who need treatment with the right dedicated solutions and professionals for their unique needs. At SCI, we believe such connections should be convenient and at your fingertips, just as so many other services are in modern society. We imagine a world where each and every person, no matter where they come from, will be able to connect with a Stem Cel Specialist instantly through our Stem Cell Innovations application (SCI Application), and in the same connection be able to decide when and how much confidential information to share with professionals.
Cryptocurrency Health
8.4
TOTAL SCORE
8.1
ICO PROFILE

(weight: 45%)

10
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
Pre-sale Time: 17 Sept 2018 - 09 Oct 2018
ICO Time: 21 Nov 2018 - 17 Jan 2019
Whitelist/KYC: KYC
Country: Gibraltar
Token info
Ticker: SCI
Platform: Ethereum
Token Type: ERC20
Available for sale: 800,000,000 SCI
Financial
ICO Price: 1 SCI = 0.15 USD
Accepting: BTC, ETH, LTC, Fiat
Soft cap: 3,000,000 USD
Hard cap: 36,000,000 USD
Social media
Links: Bitcointalk
Facebook
Twitter
Telegram
Reddit
Medium
Youtube
2013
Establishment of Camden RAD, LLC, a company devoted to stem cell research and development.
Q4 2017
Camden RAD, LLC is rebranded as Stem Cell Innovations, and a new company is established, based on blockchain technology.<br /> <br /> Advanced research begins to determine market and development opportunities.
Q1 2018
Attended Token 2049 conference in Hong Kong.<br /> <br /> Attended Stem Cell Summit at the University of California in Los Angeles (UCLA).<br /> <br /> Attended CBC conference in San Francisco, CA.<br />
Q2 2018
Attended ICO20 Summit in Santa Monica, CA.<br /> <br /> Integration of smart contract technology is established.<br /> <br /> Company headquarters incorporated in Gibraltar, GB.<br /> <br /> Strategic efforts toward development begins.<br /> <br /> Interviews with potential medical participants take place.
Q3 2018
Whitelist is scheduled to go live.<br /> <br /> Token Sale starts.
Q4 2018
Token Sale ends and min max caps are assessed.<br /> <br /> Distribution of Tokens to participants through ERC20 will commence.
Q1 2019
SCI will begin final testing and reporting based on blockchain technology being used.<br /> <br /> Creation of a non-identical patient identification factor on Passive Blockchain Node will be initialized.<br /> <br /> Demo testing for SCI Application v 1.0 will begin.
Q2 2019
Release of the SCI Application v1.1<br /> <br /> Enrollment begins for doctors, patients, and stem cell laboratories in the United States
Q3 2019
Release of Market Surveillance strategy for further growth<br /> <br /> Release SCI Application v2.0<br /> <br /> Enrollment begins for professionals, patients, and stem cell laboratories in Middle East and across North Africa.<br /> <br /> Announcement of first SCI Lab location and franchise expansion plan.
Q4 2019
Announcement of clinical development and research strategy in the stem cell field.<br /> <br /> Public announcement regarding SCI achievements to date.<br /> <br /> First ever online synthetic stem cell purchase through the SCI Application. Release SCI Application v3.0, fully functional platform for professionals and patients.
Q1 2020
Stem Cell Lab Evaluation report per first year of operation and development.<br /> <br /> Release SCI earnings and financials report.<br /> <br /> Release results of SCI's stem cell research and development to date.<br />
Q2 2020
Expansion of SCI stem cell labs and clinics in China, Japan, South Korea, and India.<br /> <br /> Begin charging membership fees (payable in Stem Cell Innovations tokens) for professional-facing portion of SCI application.
Q3 2020
Begin second phase of SCI stem cell research and development.<br /> <br /> Release SCI Application v3.5, including professional-facing component to help practitioners become more involved in the stem cell research space and contribute to the network.
Q4 2020
Expansion and acquisition of SCI stem cell labs and clinics in Europe.
Q1 2021
Release SCI earnings and financials report for second year operation and development.<br /> <br /> Release public update on SCI stem cell research and development.<br /> <br /> Stem Cell Lab Evaluation report for second year.
Q2 2021
Release SCI Application v4.0 including:<br /> <br /> A new platform for medical students, universities, and hospitals to engage with the SCI Application.<br /> <br /> Fully Functional EMR Worldwide Enforcing HIPPA and expanding of synthetic stem cell delivery to Latin America.
Screenshots taken on 13 Sep 2018
Moe Galal
Chief Executive Officer / Founder
Participates in a number of projects
Ben Barel
Chief Operations Officer / Co-Founder
Participates in a number of projects
Ali Alrashidi
Chief Technology Officer / Co-Founder
Participates in a number of projects
Matt Galal
Chief of Staff / Co-Founder
Participates in a number of projects
Kobi Barel
Operations Engineer / Co-Founder
Participates in a number of projects
John Glavinovich, M.D.
Medical Director
Participates in a number of projects
Philip Glukhovsky, D.C.
Health Informatics Manager
Participates in a number of projects
Roger Williams
VP of Marketing
Participates in a number of projects
Liz Curlett
VP, PR & Corporate Communications
Participates in a number of projects
Candice Kouchache
Business Development
Participates in a number of projects
Ahmed Elsantawi
VP of International Human Resources
Participates in a number of projects
David Marmon
Web Designer
Participates in a number of projects
Heather Deveaux
Copywriter
Participates in a number of projects
Everlecia Taylor
Creative Writer
Participates in a number of projects
Marina Evglevskaya
Administrative Manager
Participates in a number of projects
Rakel Apodaca
Product Manager
Participates in a number of projects
Michelle Chavon
Marketing
Participates in a number of projects

Advisors (7)

Boyan Josic
Participates in a number of projects
Marc X. Ellul
Participates in a number of projects
Roger Shortz, M.D.
Participates in a number of projects
Greg Maddex, D.O
Participates in a number of projects
Pantea Nakieen, M.D.
Participates in a number of projects
Shahab Sajadi
Participates in a number of projects
Igor Soshkin
Participates in a number of projects
HORIZONTAL
SQUARE
HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Upcoming
Acta Finance
The first Cross-Chain Interoperable DeFi Ecosystem, built natively on Avalanche The ActaFi Ecosystem brings a complete DeFi suite that incentivises user-base growth and motivates the user activity, offering both DeFi products and features in a single ecosystem. Every interaction within the ActaFi Ecosystem is executed on-chain, by smart contracts.
Upcoming
Hoard
Hoard is about to change the future of the video gaming industry by facilitating True Ownership of game assets on the blockchain. Today more and more people are selling virtual goods and services. With Hoard, all of this can be tokenized and made tradeable in a manner that is honest for all participants. We believe that Hoard will facilitate the global revolution in the Gaming Industry. Hoard offers a unique value-proposition to game makers and gamers alike; enabling real-world economies in games with true-ownership of virtual items, game-interoperability and new models of financing for the development of games.
Upcoming
Pharmeum
Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.
Upcoming
Retreeb
Founded in 2019 Retreeb is a sustainable fintech. We develop a decentralized, simple and sustainable mobile payment method. It is a free payment service for consumers and relies on a multi-local stablecoin network and Fantom's infrastructure. It allows its users to act in accordance with the universal values of ethics, sharing and solidarity.
Upcoming
SISHUB
The SISHUB project is developing an anonymous messenger and a decentralized system for sharing data through the utilization blockchain technologies. Does Not Log IP Address. Only complex identifiers and tunnels for data transfer will be used, which will change every 10 minutes. Absence of information collection, control over users and collection of geodata. SISHUB uses triple encryption of its own design, based on AES CBC, DSA, HMAC, when most use Curve25519, RSA 2048. All data is hashed using the SHA-2 protocol (64-bit architecture).
Upcoming
Dailycoin
DailyCoin has built a decentralized eCommerce platform, on the Ethereum Blockchain, and payment solution system. The aim is to provide that financial payment solution with little or no hassle, with next to nothing or no transaction fee, allowing people to buy or pay for those services they are used to on their platforms or merchant sites. The goal is to make everyone’s daily experience an easy one while buying those tickets, paying for shopping items or even making hotel reservations.